Does low expression of a few genes indicate good prognosis in estrogen receptor positive breast cancer?
A breast cancer subtype defined by low expression of a few genes, using a minimum of statistical modeling, has significant prognostic power. This test is of potential clinical benefit in deciding a course of treatment for early stage breast cancer patients.
These results suggest that antisense N-ras1 gene may inhibit the proliferation of cultured VSMC induced by bFGF.